产品简要
公司名称 :
安迪生物R&D
产品类型 :
ELISA/assay
产品名称 :
Human Total EGFR DuoSet IC ELISA
目录 :
DYC1854E
规格 :
1 Pack (for 15 Plates)
价格 :
1560美元
更多信息或购买 :
文章摘录数: 9
参考文献
Floc h N, Martin M, Riess J, Orme J, Staniszewska A, Ménard L, et al. Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions. Mol Cancer Ther. 2018;17:885-896 pubmed 出版商
Scharadin T, He W, Yiannakou Y, Tomilov A, Saldana M, Cortopassi G, et al. Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system. PLoS ONE. 2017;12:e0177761 pubmed 出版商
Jedlinski A, Garvin S, Johansson A, Edqvist P, Ponten F, Roberg K. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc. J Oral Pathol Med. 2017;46:717-724 pubmed 出版商
Bryan R, Regan H, Pirrie S, Devall A, Cheng K, Zeegers M, et al. Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM. Br J Cancer. 2015;112:1052-8 pubmed 出版商
Kim S, Lewis C, Nadel J. Epidermal growth factor receptor reactivation induced by E-prostanoid-3 receptor- and tumor necrosis factor-alpha-converting enzyme-dependent feedback exaggerates interleukin-8 production in airway cancer (NCI-H292) cells. Exp Cell Res. 2011;317:2650-60 pubmed 出版商
Yamashita Kashima Y, Iijima S, Yorozu K, Furugaki K, Kurasawa M, Ohta M, et al. Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models. Clin Cancer Res. 2011;17:5060-70 pubmed 出版商
O Brien N, Browne B, Chow L, Wang Y, Ginther C, Arboleda J, et al. Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinib. Mol Cancer Ther. 2010;9:1489-502 pubmed 出版商
Hickinson D, Marshall G, Beran G, Varella Garcia M, Mills E, South M, et al. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. Clin Transl Sci. 2009;2:183-92 pubmed 出版商
Shankaran H, Zhang Y, Opresko L, Resat H. Quantifying the effects of co-expressing EGFR and HER2 on HER activation and trafficking. Biochem Biophys Res Commun. 2008;371:220-4 pubmed 出版商
图像
图像 1 :
安迪生物R&D DYC1854E 图像 1
产品信息
品牌 :
R&D Systems
master code :
DYC1854-2
SKU号 :
DYC1854E
产品名称 :
Human Total EGFR DuoSet IC ELISA
描述 :
The Human Total EGFR DuoSet IC ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human EGFR.
靶标 :
表皮生长因子受体
类别 :
ELISAs
单位尺寸 :
1 Pack (for 15 Plates)
物种 :
人类
基因符号 :
表皮生长因子受体
kit type :
Solid Phase Sandwich ELISA
assay length :
4 hours 40 mins (after plate preparation)
elisaRange :
31.20 - 2000 pg/mL
应用 :
酶联免疫吸附测定
美元2021 :
1525
美元2022 :
1560美元
别名 :
avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1
储存 :
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
更多信息或购买 :
公司信息
安迪生物R&D
上海市长宁区延安西路726号华敏翰尊国际大厦24A1
info@rndsystemschina.com.cn
http://www.rndsystemschina.com.cn
21 52380373
公司总部: 美国
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.